Keiju Aokage

9.7k total citations · 3 hit papers
186 papers, 4.9k citations indexed

About

Keiju Aokage is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Keiju Aokage has authored 186 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Pulmonary and Respiratory Medicine, 73 papers in Oncology and 35 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Keiju Aokage's work include Lung Cancer Diagnosis and Treatment (116 papers), Lung Cancer Treatments and Mutations (93 papers) and Radiomics and Machine Learning in Medical Imaging (32 papers). Keiju Aokage is often cited by papers focused on Lung Cancer Diagnosis and Treatment (116 papers), Lung Cancer Treatments and Mutations (93 papers) and Radiomics and Machine Learning in Medical Imaging (32 papers). Keiju Aokage collaborates with scholars based in Japan, United States and United Kingdom. Keiju Aokage's co-authors include Masahiro Tsuboi, Genichiro Ishii, Tomoyuki Hishida, Junji Yoshida, Kanji Nagai, Kenji Suzuki, Hisashi Saji, Hisao Asamura, Shun‐ichi Watanabe and Morihito Okada and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Keiju Aokage

168 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

2022 764 citations Hisashi Saji, Morihito Okada et al. profile →
Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial

2019 310 citations Kenji Suzuki, Hisashi Saji et al. Journal of Thoracic and Cardiovascular Surgery profile →
A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer

2020 198 citations Kenji Suzuki, Shun‐ichi Watanabe et al. Journal of Thoracic and Cardiovascular Surgery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keiju Aokage Japan	36	3.5k	1.7k	1.1k	656	498	186	4.9k
Haruhiko Nakayama Japan	39	4.0k 1.1×	1.3k 0.8×	1.2k 1.1×	682 1.0×	308 0.6×	190	5.3k
Tomoyuki Hishida Japan	40	2.6k 0.7×	1.7k 1.0×	666 0.6×	584 0.9×	331 0.7×	150	4.1k
Kyuichi Kadota Japan	40	3.2k 0.9×	1.9k 1.1×	773 0.7×	647 1.0×	387 0.8×	132	5.1k
Dorothy J. Giroux United States	23	5.8k 1.6×	2.2k 1.3×	1.4k 1.3×	883 1.3×	136 0.3×	39	7.3k
Makoto Sonobe Japan	36	2.8k 0.8×	1.5k 0.9×	460 0.4×	779 1.2×	244 0.5×	224	4.8k
Morihito Okada Japan	40	6.2k 1.8×	1.5k 0.9×	1.8k 1.6×	1.2k 1.9×	113 0.2×	280	7.1k
Kazuya Takamochi Japan	35	3.2k 0.9×	1.0k 0.6×	996 0.9×	552 0.8×	87 0.2×	227	3.9k
Masashi Wakabayashi Japan	23	1.9k 0.5×	1.4k 0.8×	515 0.5×	808 1.2×	207 0.4×	136	3.2k
Noriaki Tsubota Japan	39	4.6k 1.3×	1.7k 1.0×	844 0.8×	964 1.5×	86 0.2×	143	5.8k
Jun‐ichi Nitadori Japan	27	1.8k 0.5×	980 0.6×	478 0.4×	307 0.5×	307 0.6×	61	2.5k

Countries citing papers authored by Keiju Aokage

Since Specialization

Citations

This map shows the geographic impact of Keiju Aokage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiju Aokage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiju Aokage more than expected).

Fields of papers citing papers by Keiju Aokage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiju Aokage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiju Aokage. The network helps show where Keiju Aokage may publish in the future.

Co-authorship network of co-authors of Keiju Aokage

This figure shows the co-authorship network connecting the top 25 collaborators of Keiju Aokage. A scholar is included among the top collaborators of Keiju Aokage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiju Aokage. Keiju Aokage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sasaki, Tomoaki, Hirofumi Kuno, Keiichi Nomura, et al.. (2025). CZT-based photon-counting-detector CT with deep-learning reconstruction: image quality and diagnostic confidence for lung tumor assessment. Japanese Journal of Radiology. 43(7). 1132–1144.

Tsuboi, Masahiro, Li Zhou, Cheng He, et al.. (2024). Potential of circulating micrornas as biomarkers in perioperative management of lung cancer. 5. 100258–100258. 1 indexed citations

Nomura, Kotaro, Keiju Aokage, Tokiko Nakai, et al.. (2024). EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system. International Journal of Clinical Oncology. 29(3). 248–257. 2 indexed citations

Aokage, Keiju, Shohei Koyama, Shogo Kumagai, et al.. (2024). Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY). Clinical Cancer Research. 30(24). 5584–5592. 4 indexed citations

Wakabayashi, Masashi, Makoto Tada, Tomohiro Miyoshi, et al.. (2024). Effect of Resected Lung Volume on Pulmonary Function and Residual Lung Volume in Patients Undergoing Segmentectomy: A Retrospective Study. Annals of Surgical Oncology. 31(10). 6645–6651. 1 indexed citations

Aokage, Keiju, Masashi Wakabayashi, Takashi Ikeno, et al.. (2024). Long-term outcomes of 5-year survivors without recurrence after the complete resection of non-small cell lung cancer after lobectomy: a landmark analysis in consideration of competing risks. Surgery Today. 54(9). 1005–1014. 2 indexed citations

Nagasaki, Yusuke, Tetsuro Taki, Kotaro Nomura, et al.. (2024). Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer. JNCI Journal of the National Cancer Institute. 116(7). 1158–1168.

Tane, Kenta, Satoshi Shiono, Masashi Wakabayashi, et al.. (2024). A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX). Japanese Journal of Clinical Oncology. 54(8). 926–929. 1 indexed citations

Sekino, Yuta, Tomoyuki Hishida, Hiroshige Yoshioka, et al.. (2024). Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG). Japanese Journal of Clinical Oncology. 55(2). 176–182.

10.

Miyoshi, Tomohiro, et al.. (2023). Predictors of residual simultaneous multiple ground-glass nodule progression after dominant lesion resection. General Thoracic and Cardiovascular Surgery. 72(3). 183–191. 1 indexed citations

11.

Yoshino, Ichiro, Yasumitsu Moriya, Kenji Suzuki, et al.. (2023). Long-term outcome of patients with peripheral ground-glass opacity–dominant lung cancer after sublobar resections. Journal of Thoracic and Cardiovascular Surgery. 166(4). 1222–1231.e1. 12 indexed citations

12.

Takamori, Shinkichi, Yasushi Yatabe, Atsushi Osoegawa, et al.. (2023). Rare but clinically important salivary gland-type tumor of the lung: A review. Japanese Journal of Clinical Oncology. 54(2). 121–128. 2 indexed citations

13.

Kitagawa, Shingo, Yoshitaka Zenke, Tetsuro Taki, et al.. (2023). Prognostic value of predominant subtype in pathological stage II–III lung adenocarcinoma with epidermal growth factor receptor mutation. Lung Cancer. 188. 107453–107453. 3 indexed citations

14.

Itahashi, Kota, Takuma Irie, Junichiro Yuda, et al.. (2022). BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors. Science Immunology. 7(76). eabk0957–eabk0957. 60 indexed citations

15.

Aokage, Keiju, Masahiro Tsuboi, Yoshitaka Zenke, et al.. (2022). Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer. Japanese Journal of Clinical Oncology. 52(4). 383–387. 5 indexed citations

16.

Sakai, Takashi, Keiju Aokage, Shinya Katsumata, et al.. (2021). Continuation of aspirin perioperatively for lung resection: a propensity matched analysis. Surgery Today. 51(6). 1054–1060.

17.

Miyoshi, Tomohiro, Keiju Aokage, Jun Suzuki, et al.. (2021). Prognostic impact of the tumor immune microenvironment in pulmonary pleomorphic carcinoma. Lung Cancer. 153. 56–65. 10 indexed citations

18.

Sakai, Takashi, Keiju Aokage, Shinya Neri, et al.. (2018). Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma. Lung Cancer. 126. 64–71. 46 indexed citations

19.

Miyoshi, Tomohiro, Shigeki Umemura, Yuki Matsumura, et al.. (2016). Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clinical Cancer Research. 23(3). 757–765. 139 indexed citations

20.

Yoshida, Junji, Genichiro Ishii, Tomoyuki Hishida, et al.. (2015). Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography--interim results. Japanese Journal of Clinical Oncology. 45(7). 677–681. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact